Intrinsic Therapeutics, Inc

Intrinsic Therapeutics, Inc. is a medical device company specializing in the prevention of reherniation and reoperation following lumbar discectomy surgery. Their flagship product, Barricaid, is an FDA-approved bone-anchored implant designed to close large defects in the annulus of the disc after the removal of a herniated disc. This device helps to reduce the risk of the disc herniating again, leading to less pain, faster recovery times, and fewer reoperations. The company boasts robust clinical evidence with eight distinct patient populations studied, including two randomized controlled trials and six single-arm trials.

Intrinsic Therapeutics is committed to improving the lives of patients suffering from lumbar herniation. They have been working for two decades to develop the Barricaid solution, partnering with world-renowned surgeons, scientists, clinical investigators, and medical advisors. The company has achieved significant milestones, including FDA Pre-Market Approval, CMS C-code for billing and payment, and CDC ICD-10 codes to track defect size in discectomy patients. Their continued efforts focus on expanding access to Barricaid and driving commercial growth in the medical device industry.

Intrinsic Therapeutics does not explicitly mention job flexibility or remote work options on their website or in the provided job posting. NONE

Intrinsic Therapeutics is dedicated to reducing unnecessary suffering by making its Barricaid® device, a bone-anchored implant for large annular defects, accessible to patients and surgeons. The company's vision is to create a world where lumbar herniation doesn't define lives, and they are committed to this mission by collaborating with world-renowned surgeons, scientists, and medical advisors to develop and provide solutions for patients at high risk of recurrence following discectomy.

Intrinsic Therapeutics promotes a culture focused on innovation and patient-centricity. They emphasize collaboration with world-renowned surgeons and researchers to develop evidence-based solutions for patients with herniated discs. The company's commitment to clinical research and its dedication to improving patient outcomes are core values reflected in its work environment.

Intrinsic Therapeutics, Inc. does not explicitly mention their approach to diversity, equity, and inclusion on their website. NONE